Hemoglobin Saturation in Superior Vena Cava and Right Atrium
NCT ID: NCT01398436
Last Updated: 2013-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
61 participants
INTERVENTIONAL
2011-03-31
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study is carried out in patients that undergo central venous and pulmonary artery catheterization for surgical coronary revascularization. In the interventional group (atrium, A), the tip of the central venous catheter (CVC) is placed in the right atrium; in the control group (control, C), the tip is placed in the superior vena cava. In both groups, CVC position is confirmed with transesophageal echocardiography (TEE). At fixed times during surgery and in the following 72 hours, heparinized blood samples are collected from the proximal and distal CVC lumens and from the distal lumen of the pulmonary catheter (PC) and oxygen saturation is measured by an oximeter. Besides, mechanical and electrical complications potentially influenced by CVC position are registered.
1. The primary aim of the study will be achieved by performing the following analysis on values from CVC proximal and distal lumens:
1. a Bland Altman analysis between proximal and distal oxygen saturation in group A, in order to evaluate if the two measures are equivalent
2. a comparison of the difference between proximal and distal oxygen saturation in groups A and C in order to rule out random errors
2. In addition:
1. differences in oxygen saturation between proximal or distal CVC and distal PC will be compared in order to evaluate whether distal saturation is more indicative of mixed venous saturation
2. differences between proximal and distal oxygen saturation will be correlated with cardiac index and PCWP to investigate if low cardiac output and hypovolemia increase differences
3. The secondary aim of the study will be achieved by comparing the incidence of cardiac arrhythmias in groups A and C
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Difference in Subclavian Vein Catheterization Between Supine and Lateral Tilt Position - Stage I
NCT03296735
Siting Central Venous Catheters Precisely While Performing the Access Procedure
NCT05751395
Comparison Between Supraclavicular And Infraclavicular Approach For Right Subclavian Venous Catheterization
NCT05140668
Correlation Between External Jugular Venous and Superior Vena Cava Central Venous Blood Oxygen Saturation in Patient Under General Anesthesia
NCT04017182
Complications and Failure of Centrally Inserted Central Catheters in Cardiac Surgical Patients
NCT07138690
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Arrow catheters (3 lumen, 8,5 Fr, 20 cm long) will be used. Catheters will be placed in right internal jugular or subclavian vein with Seldinger technique. In group A, the catheter will be advanced for its entire length unless arrhythmias develop; in group C the catheter will be inserted for 15 cm. Catheter position will be controlled by transesophageal echocardiography and/or by chest radiography. In order to avoid risk of damage to the atrial wall, ECG and central venous pressure will be monitored during the entire observation period, and the catheter will be repositioned, withdrawing it, in presence of extrasystoles or other arrhythmias potentially triggered by contact between the catheter tip and the heart wall, in case of flattening of the curve of the central venous pressure (caused by contact with the atrial wall) or in presence of a ventricular type of curve (migration of the catheter in the right ventricle through the tricuspid valve). The catheter tip will be removed or repositioned in superior vena cava at the time of mobilization of the patient or of his transfer to another unit.
A sample of arterial blood from an arterial line, one of mixed venous blood from the pulmonary catheter and two samples from the CVC, one from the distal lumen and a proximal lumen, will be taken at different times: time 1, at CVC placement; time 2, after sternotomy; time 3, after after discontinuation of CBP; time 4, at admission to ICU; time 5, 6,7 8, respectively 6, 18, 30 and 42 hours after the end of surgery. Samples volume of 1 mL will be collected in heparinized syringes and immediately analyzed by a stat analyzer (Stat Profile Critical Care Xpress by Nova Biomedical) with integrated on-board CO-Oximetry, allowing direct measurement of oxygen saturation.
The values of pH, pO2, pCO2 and saturation of venous samples will be compared and the difference will be analyzed by Bland-Altman method. The observed difference will also be correlated with indexes of tissue perfusion (arterial base excess, arterial plasma lactate) and with the presence and dose of vasoactive drugs infusion.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Catheter tip in right atrium
In this group a central venous catheter will be advanced for its entire length unless arrhythmias develop.Catheter position will be controlled by transesophageal echocardiography and/or by chest radiography.
central venous catheter positioning in right atrium
A central venous catheter will be advanced for its entire length unless arrhythmias develop. Catheter position will be controlled by transesophageal echocardiography and/or by chest radiography
Catheter tip in superior vena cava
In this group a central venous catheter will be inserted for 15 cm in accordance with standard practice. Catheter position will be controlled by transesophageal echocardiography and/or by chest radiography
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
central venous catheter positioning in right atrium
A central venous catheter will be advanced for its entire length unless arrhythmias develop. Catheter position will be controlled by transesophageal echocardiography and/or by chest radiography
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* contraindication to catheterization through the right internal jugular or right subclavian vein
* presence of inflammatory disease of the heart (eg myocarditis) or any other disease increasing the risk of complications
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Catholic University of the Sacred Heart
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Franco Cavaliere
Associate Professor of Anaesthesia and Intensive Care
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Franco Cavaliere, Professor
Role: PRINCIPAL_INVESTIGATOR
Catholic University of Sacred Heart, Rome
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Università Cattolica del Sacro Cuore - Policlinico "A. Gemelli"
Rome, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dueck MH, Klimek M, Appenrodt S, Weigand C, Boerner U. Trends but not individual values of central venous oxygen saturation agree with mixed venous oxygen saturation during varying hemodynamic conditions. Anesthesiology. 2005 Aug;103(2):249-57. doi: 10.1097/00000542-200508000-00007.
Edwards JD, Mayall RM. Importance of the sampling site for measurement of mixed venous oxygen saturation in shock. Crit Care Med. 1998 Aug;26(8):1356-60. doi: 10.1097/00003246-199808000-00020.
Chawla LS, Zia H, Gutierrez G, Katz NM, Seneff MG, Shah M. Lack of equivalence between central and mixed venous oxygen saturation. Chest. 2004 Dec;126(6):1891-6. doi: 10.1378/chest.126.6.1891.
Pikwer A, Baath L, Davidson B, Perstoft I, Akeson J. The incidence and risk of central venous catheter malpositioning: a prospective cohort study in 1619 patients. Anaesth Intensive Care. 2008 Jan;36(1):30-7. doi: 10.1177/0310057X0803600106.
Webster CS, Merry AF, Emmens DJ, Van Cotthem IC, Holland RL. A prospective clinical audit of central venous catheter use and complications in 1000 consecutive patients. Anaesth Intensive Care. 2003 Feb;31(1):80-6. doi: 10.1177/0310057X0303100116.
Cavaliere F, Zamparelli R, Martinelli L, Scapigliati A, De Paulis S, Caricato A, Gargaruti R, Cina A. Blood from the right atrium may provide closer estimates of mixed venous saturation than blood from the superior vena cava. A pilot study. Minerva Anestesiol. 2014 Jan;80(1):11-8. Epub 2013 Jul 15.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
P/999/CE/2010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.